Jupiter Wellness Inc. (JUPW): Price and Financial Metrics

Jupiter Wellness Inc. (JUPW): $1.49

-0.05 (-3.25%)

POWR Rating

Component Grades













Add JUPW to Watchlist
Sign Up

Industry: Consumer Goods


of 71

in industry


  • Sentiment is the dimension where JUPW ranks best; there it ranks ahead of 60.75% of US stocks.
  • The strongest trend for JUPW is in Quality, which has been heading down over the past 44 weeks.
  • JUPW ranks lowest in Stability; there it ranks in the 0th percentile.

JUPW Stock Summary

  • Jupiter Wellness Inc's market capitalization of $35,308,296 is ahead of only 3.58% of US-listed equities.
  • Jupiter Wellness Inc's stock had its IPO on October 30, 2020, making it an older stock than just 0.07% of US equities in our set.
  • The volatility of Jupiter Wellness Inc's share price is greater than that of 94.69% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Jupiter Wellness Inc, a group of peers worth examining would be TRC, GNUS, CNET, SOS, and CD.
  • JUPW's SEC filings can be seen here. And to visit Jupiter Wellness Inc's official web site, go to jupiterwellnessinc.com.

JUPW Valuation Summary

  • JUPW's price/sales ratio is 36.4; this is 857.89% higher than that of the median Healthcare stock.
  • JUPW's price/sales ratio has moved down 7863.6 over the prior 44 weeks.
  • Over the past 44 weeks, JUPW's EV/EBIT ratio has gone up 50.1.

Below are key valuation metrics over time for JUPW.

Stock Date P/S P/B P/E EV/EBIT
JUPW 2021-08-31 36.4 11.1 -3.5 -3.5
JUPW 2021-08-30 34.6 10.5 -3.3 -3.3
JUPW 2021-08-27 33.0 10.1 -3.2 -3.2
JUPW 2021-08-26 34.4 10.5 -3.3 -3.3
JUPW 2021-08-25 35.0 10.7 -3.4 -3.4
JUPW 2021-08-24 35.2 10.7 -3.4 -3.4

JUPW's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • JUPW has a Quality Grade of F, ranking ahead of 1.1% of graded US stocks.
  • JUPW's asset turnover comes in at 0.23 -- ranking 47th of 50 Consumer Goods stocks.
  • 500 - Internal server error

The table below shows JUPW's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.230 0.361 -51.910
2021-03-31 0.260 0.450 -38.094
2021-03-31 0.260 0.450 -38.094
2020-12-31 0.293 0.414 -62.901

JUPW Stock Price Chart Interactive Chart >

Price chart for JUPW

JUPW Price/Volume Stats

Current price $1.49 52-week high $8.88
Prev. close $1.54 52-week low $1.49
Day low $1.49 Volume 433,000
Day high $1.57 Avg. volume 479,580
50-day MA $2.20 Dividend yield N/A
200-day MA $4.35 Market Cap 34.16M

Jupiter Wellness Inc. (JUPW) Company Bio

Jupiter Wellness, Inc. is a wellness brand dedicated to exploring the multiple therapeutic and medical uses of cannabidiol via a collection of convenient consumer products. Its brands include CaniSun, CaniSkin, CaniDermRx and CaniSweet. The company was founded by Brian S. John on October 24, 2018 and is headquartered in Jupiter, FL.

JUPW Latest News Stream

Event/Time News Detail
Loading, please wait...

JUPW Latest Social Stream

Loading social stream, please wait...

View Full JUPW Social Stream

Latest JUPW News From Around the Web

Below are the latest news stories about Jupiter Wellness Inc that investors may wish to consider to help them evaluate JUPW as an investment opportunity.

Jupiter Wellness Announces Multi-Year Extension of Endorsement Agreement with Pro Golfer Ernie Els

Pro Golf Hall of Fame Legend Extends Endorsement of CaniSun Suncare ProductsJUPITER, FL / ACCESSWIRE / September 8, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a developer of enhanced skin care therapeutics, sunscreens and treatments focused on the endocannabinoid system, today announced a multi-year extension of its endorsement agreement with PGA Golf Legend Ernie Els.

Yahoo | September 8, 2021

Jupiter Wellness Submitted a Pre-IND Meeting Request with the US FDA for its Proposed Clinical Program of JW-100 as a Treatment for Mild to Moderate Eczema

Following receipt of a Pre-Assignment number from the FDA Jupiter Wellness requests Pre-IND meetingJUPITER, FL / ACCESSWIRE / August 23, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a developer of enhanced skin care therapeutics and treatments focused on the endocannabinoid system today announced it has submitted a pre-IND (Investigational New Drug) meeting request with the U.

Yahoo | August 23, 2021

Jupiter Wellness Applies for IND number from the US Food and Drug Administration

Following positive results from the JW-100 investigator initiated trials for Eczema, Jupiter Wellness to commence US FDA programJUPITER, FL / ACCESSWIRE / August 16, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced it has requested an IND number from the US Federal Drug Administration in preparation for a pre-IND submission to review preclinical and clinical studies for the use of JW-100 in the treatment of patients with mild to moderate eczema.

Yahoo | August 16, 2021

Aegis Capital Corp. acted as Sole Bookrunner on a $32.5 Million Follow-On Offering of Common Stock and Warrants for Jupiter Wellness, Inc. (NASDAQ:JUPW).

NEW YORK, NY / ACCESSWIRE / July 26, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $32.

Yahoo | July 26, 2021

Jupiter Wellness Closes $32.5 Million Underwritten Public Offering of Common Stock and Warrants

JUPITER, FL / ACCESSWIRE / July 26, 2021 / Jupiter Wellness, Inc. (the "Company") (NASDAQ:JUPW), today announced the closing of an underwritten public offering (the "Offering") of 11,066,258 shares (the "Company Offering Shares") of common stock, par value $0.

Yahoo | July 26, 2021

Read More 'JUPW' Stories Here

JUPW Price Returns

1-mo -5.70%
3-mo -65.51%
6-mo -73.15%
1-year N/A
3-year N/A
5-year N/A
YTD -70.73%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.8213 seconds.